Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells.
Journal Information
Full Title: Exp Hematol Oncol
Abbreviation: Exp Hematol Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateAll animal experiments have been supervised and approved by the Laboratory Animal Ethics and Management Committee of Xiamen University. Consent for publicationAll contributors have agreed to publish this manuscript. Competing interestsThere is no conflicting interest to declare. Competing interests There is no conflicting interest to declare."
"Funding This work was financially supported by the National Natural Science Foundation of China (No. 81770126, 81770161) and the Natural Science Foundation of Fujian Province, China (No. 2020J011239, 2021J011348)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025